Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS often have mood disorders and a lower quality of life, and treatment should focus on both physical and mental health.

Hormones and neuroendocrine factors control hair growth and color, and more research could lead to new hair treatment options.

Negative expectations can cause adverse effects in patients even without active treatment, and managing this nocebo effect involves better communication and patient-clinician relationships.

Chronic stress can reduce skin pigmentation.

Neurosteroids change how GABA_A receptors work in the brain, which could be important for treating temporal lobe epilepsy.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Some people experience severe, long-lasting side effects from fluoroquinolone antibiotics, leading to the recommendation of limited use and increased awareness of these risks.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

About 8.5% of women in Salvador, Brazil, have Polycystic Ovary Syndrome.

Early detection and stopping the drug are key to managing DRESS, and careful monitoring is important due to possible severe reactions.

Reproductive factors can increase hypertension risk and affect cardiovascular health.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

Testosterone causes hair loss in AGA mice, which are good for testing baldness treatments, and both minoxidil and cyproterone acetate can prevent this hair loss.

Hirsutism is excessive male-pattern hair growth in women, often caused by hormonal imbalances, and requires ongoing treatment to manage.

Bariatric surgery may help severely obese teenagers but has risks and requires careful patient selection and long-term care.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Topical finasteride and flutamide reduce gland size and enzyme activity, with flutamide being more potent, potentially treating acne, seborrhea, hirsutism, and androgenic alopecia.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Women with PCOS tend to have higher anxiety and depression levels compared to healthy women.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

The exact cause of increased 5α-reductase activity leading to hirsutism in women is still unknown.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Hair loss linked to metabolic issues and insulin resistance; early assessment may reduce future health risks.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

Stress and emotional factors can worsen skin conditions by affecting the immune system.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

Measuring reproductive hormones in brown bear hair could help identify their sex and reproductive state, but better collection methods or lab techniques are needed.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.